Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

SHA:600521 Revenue

Zhejiang Huahai Pharmaceutical had revenue of 2.37B CNY in the quarter ending March 31, 2025, with 12.73% growth. This brings the company's revenue in the last twelve months to 9.35B, up 8.26% year-over-year. In the year 2023, Zhejiang Huahai Pharmaceutical had annual revenue of 8.31B with 0.52% growth.

• Revenue (ttm): 9.35B
• Revenue Growth: +8.26%
• P/S Ratio: 2.28
• Revenue / Employee: 1.15M
• Employees: 8,221
• Market Cap: 21.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.31B	42.97M	0.52%
Dec 31, 2022	8.27B	1.62B	24.42%
Dec 31, 2021	6.64B	158.36M	2.44%
Dec 31, 2020	6.49B	1.10B	20.36%
Dec 31, 2019	5.39B	293.50M	5.76%